Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
46.47 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 66.408 | 48.118 | 40.813 | 27.614 | 13.076 | 1.871 | 15.277 | 2.5 | 10 | 0 | 15.277 | 0.539 | 0.338 | 1.24 | 22.017 | 33.432 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 4.926 | 3.242 | 3.004 | 1.654 | 1.216 | 0.377 | 0.316 | 0.255 | 0.4 | 10.912 | 0.522 | 0.033 | 8.014 | 0.065 | 0.737 | 1.297 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 61.482 | 44.876 | 37.809 | 25.96 | 11.86 | 1.494 | 14.961 | 2.245 | 9.6 | -10.912 | 14.755 | 0.506 | -7.676 | 1.175 | 21.28 | 32.135 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.926 | 0.933 | 0.926 | 0.94 | 0.907 | 0.799 | 0.979 | 0.898 | 0.96 | 0 | 0.966 | 0.939 | -22.71 | 0.948 | 0.967 | 0.961 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 16.873 | 12.128 | 12.319 | 12.066 | 13.305 | 12.105 | 12.546 | 12.356 | 10.028 | 10.912 | 9.603 | 12.081 | 8.038 | 10.209 | 7.204 | 16.261 | 7.587 | 7.991 | 1.737 | 1.512 | 0.697 | 0.399 | 0.225 | 0.225 |
| General & Administrative Expenses
| 0 | 0 | 58.792 | 0 | 65.695 | 30.324 | 20.275 | 15.096 | 14.633 | 11.994 | 10.376 | 7.946 | 6.772 | 6.671 | 6.794 | 5.16 | 3.89 | 2.15 | 1.526 | 0.606 | 0.387 | 0.234 | 0.112 | 0.112 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | -22.69 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 69.03 | 57.91 | 58.792 | 51.578 | 43.005 | 30.324 | 20.275 | 15.096 | 14.633 | 11.994 | 10.376 | 7.946 | 6.772 | 6.671 | 6.794 | 5.16 | 3.89 | 2.15 | 1.526 | 0.606 | 0.387 | 0.234 | 0.112 | 0.112 |
| Other Expenses
| 0 | 0 | 0 | 0.605 | -0.013 | -0.048 | -0.047 | 0.006 | -0.05 | -0.007 | 0.106 | 0.037 | -0.005 | 0.005 | -0.039 | -0.034 | 4.282 | 0 | 0 | 0 | 0 | 0 | -0.675 | -0.675 |
| Operating Expenses
| 85.903 | 70.038 | 71.111 | 63.644 | 56.31 | 42.429 | 32.821 | 27.452 | 24.661 | 22.906 | 19.979 | 20.027 | 14.81 | 16.88 | 13.998 | 21.421 | 11.477 | 10.141 | 3.263 | 2.118 | 1.084 | 0.633 | -0.338 | -0.338 |
| Operating Income
| -24.421 | -25.162 | -33.302 | -37.684 | -44.45 | -40.935 | -32.821 | -24.952 | -15.061 | -22.906 | -5.224 | -19.521 | -14.448 | -15.705 | 7.282 | 10.714 | -11.477 | -10.141 | -3.263 | -2.118 | -1.084 | -0.633 | -0.338 | -0.338 |
| Operating Income Ratio
| -0.368 | -0.523 | -0.816 | -1.365 | -3.399 | -21.879 | -2.148 | -9.981 | -1.506 | 0 | -0.342 | -36.217 | -42.746 | -12.665 | 0.331 | 0.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.308 | 1.742 | 0.012 | 1.953 | 2.548 | 1.787 | 1.397 | 1.533 | 1.462 | 0.39 | -0.519 | -0.716 | -0.349 | -0.333 | -0.908 | -0.025 | 0.01 | 0.004 | 0.013 | 0.161 | -0.328 | -0.048 | 0.008 | 0.008 |
| Income Before Tax
| -23.113 | -23.42 | -33.29 | -35.731 | -41.902 | -40.935 | -31.424 | -23.419 | -13.599 | -22.516 | -5.743 | -20.237 | -14.797 | -16.038 | 6.374 | 10.689 | -11.467 | -10.137 | -3.25 | -1.957 | -1.412 | -0.681 | -0.33 | -0.33 |
| Income Before Tax Ratio
| -0.348 | -0.487 | -0.816 | -1.294 | -3.204 | -21.879 | -2.057 | -9.368 | -1.36 | 0 | -0.376 | -37.545 | -43.778 | -12.934 | 0.29 | 0.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | -0.27 | 30.398 | -1.787 | -27.078 | -1.533 | -0.521 | -0.005 | 0.519 | 0.001 | 0.054 | -0.341 | 0.029 | 0.313 | -0.001 | 0.001 | 0 | 0 | 0.328 | 0.048 | 0 | 0 |
| Net Income
| -23.113 | -23.42 | -33.29 | -35.731 | -41.902 | -39.148 | -31.424 | -21.886 | -13.078 | -22.511 | -6.262 | -20.238 | -14.851 | -15.697 | 6.345 | 10.376 | -11.467 | -10.138 | -3.25 | -1.957 | -1.412 | -0.681 | -0.33 | -0.33 |
| Net Income Ratio
| -0.348 | -0.487 | -0.816 | -1.294 | -3.204 | -20.924 | -2.057 | -8.754 | -1.308 | 0 | -0.41 | -37.547 | -43.938 | -12.659 | 0.288 | 0.31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.61 | -0.61 | -0.88 | -1.01 | -1.31 | -1.28 | -1.17 | -0.82 | -0.49 | -0.84 | -0.26 | -0.98 | -0.72 | -0.76 | 0.31 | 0.51 | -0.56 | -0.54 | -0.3 | -0.18 | -0.13 | -0.063 | -0.077 | -0.077 |
| EPS Diluted
| -0.61 | -0.61 | -0.88 | -1.01 | -1.31 | -1.28 | -1.17 | -0.82 | -0.49 | -0.84 | -0.26 | -0.98 | -0.72 | -0.76 | 0.29 | 0.47 | -0.53 | -0.54 | -0.3 | -0.18 | -0.13 | -0.063 | -0.077 | -0.077 |
| EBITDA
| -20.507 | -20.675 | -30.942 | -34.478 | -40.566 | -37.921 | -30.293 | -22.48 | -12.688 | -21.672 | -5.107 | -19.767 | -14.408 | -15.864 | 7.407 | 10.778 | -11.437 | -10.117 | -3.246 | -2.103 | -1.065 | -0.624 | -0.329 | -0.329 |
| EBITDA Ratio
| -0.309 | -0.43 | -0.758 | -1.365 | -3.373 | -21.879 | -1.994 | -9.061 | -1.298 | 0 | -0.311 | -35.33 | -41.574 | -12.319 | 0.376 | 0.322 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |